Literature DB >> 11705709

Association of ZNF74 gene genotypes with age-at-onset of schizophrenia.

K Takase1, T Ohtsuki, O Migita, M Toru, T Inada, K Yamakawa-Kobayashi, T Arinami.   

Abstract

Because of the manifestation of schizophrenic symptoms in individuals with interstitial deletions of chromosome 22q11.2, genes located in 22q11.2 are positional candidates for schizophrenia susceptibility. We genotyped five polymorphisms at D22S941, D22S944, D22S264, and D22S311, and the COMT gene in the common 3Mbp deletion region associated with 22q11 deletion syndrome in 300 Japanese schizophrenics and 300 controls and identified one patient with 22q11 deletion (Arinami et al., 2001). The results showed a trend of different genotypic distributions in D22S264 between patients with schizophrenia and controls (non-corrected p=0.04). Given this finding, we searched for mutations in the ZNF74 gene, which is located 11.2Kbp centromeric to D22S264. The ZNF74 gene is a member of the KRAB-zinc finger gene family and is expressed in the developing brain. Four polymorphisms, 1150T/C, IVS2a-40G/A, E/K46, and [K/N551;L/F552], were detected. The first three polymorphisms were in almost complete linkage disequilibrium. Case-control comparisons for these polymorphisms resulted in similar genotypic and allelic frequencies in patients and controls. The polymorphisms, however, were significantly associated with age-at-onset of schizophrenia (n<0.0001). Subsequent analyses in another Japanese schizophrenic population (n=169) confirmed an age-at-onset association (p<0.0001). These findings suggest that the ZNF74 gene plays a role as one of the modifying factors for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705709     DOI: 10.1016/s0920-9964(00)00191-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

Review 1.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

2.  The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhilong Yang; Charles Wood
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.

Authors:  H Wang; S Duan; J Du; X Li; Y Xu; Z Zhang; Y Wang; G Huang; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-01-25       Impact factor: 3.575

Review 4.  Genetically mediated brain abnormalities in schizophrenia.

Authors:  Larry J Seidman; Heidi E Wencel
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

5.  Novel mutations in WWOX, RARS2, and C10orf2 genes in consanguineous Arab families with intellectual disability.

Authors:  Asem M Alkhateeb; Samah K Aburahma; Wesal Habbab; I Richard Thompson
Journal:  Metab Brain Dis       Date:  2016-04-28       Impact factor: 3.584

6.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Authors:  M Daniele Fallin; Virginia K Lasseter; Dimitrios Avramopoulos; Kristin K Nicodemus; Paula S Wolyniec; John A McGrath; Gary Steel; Gerald Nestadt; Kung-Yee Liang; Richard L Huganir; David Valle; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2005-10-28       Impact factor: 11.025

7.  Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain.

Authors:  Elizabeth Spiteri; Genevieve Konopka; Giovanni Coppola; Jamee Bomar; Michael Oldham; Jing Ou; Sonja C Vernes; Simon E Fisher; Bing Ren; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

8.  Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia.

Authors:  Ke-Sheng Wang; Lingjun Zuo; Daniel Owusu; Yue Pan; Xingguang Luo
Journal:  J Schizophr Res       Date:  2014-08-01

9.  Supportive evidence for reduced expression of GNB1L in schizophrenia.

Authors:  Hiroki Ishiguro; Minori Koga; Yasue Horiuchi; Emiko Noguchi; Miyuki Morikawa; Yoshimi Suzuki; Makoto Arai; Kazuhiro Niizato; Shyuji Iritani; Masanari Itokawa; Toshiya Inada; Nakao Iwata; Norio Ozaki; Hiroshi Ujike; Hiroshi Kunugi; Tsukasa Sasaki; Makoto Takahashi; Yuichiro Watanabe; Toshiyuki Someya; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyuki Nawa; Tadao Arinami
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

10.  Analysis of TBX1 variation in patients with psychotic and affective disorders.

Authors:  Birgit H Funke; Todd Lencz; Christine T Finn; Pamela DeRosse; G David Poznik; Alex M Plocik; John Kane; John Rogus; Anil K Malhotra; Raju Kucherlapati
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.